EIB grants €15 million to finance growth of Smart Reporting
The European Investment Bank (EIB) has granted a venture debt loan of €15 million to support health-tech start-up Smart Reporting during its growth...
Diagnosing and treating cancer early are among the most pressing health challenges that the world faces. Quite simply, without accurate, quality pathological diagnoses, patients cannot be treated. Pathologists’ reports on cancer biopsies and resections provide the critical data—diagnosis, staging, and critical prognostic and predictive information—required for clinical management and feeding information into cancer registries.
In many of the countries where C/Can works, pathology reports are still written out in narrative form, with no guidelines or standardisation, despite the International Collaboration on Cancer Reporting’s (ICCR) internationally-agreed, evidence-informed datasets, which are aimed specifically at ensuring complete and conformant cancer reports for treatment and epidemiology.
The European Investment Bank (EIB) has granted a venture debt loan of €15 million to support health-tech start-up Smart Reporting during its growth...
Munich, February 2023. Smart Reporting is excited to announce that following a stellar business performance in what can be described as a challenging...
1 min read
Munich, Germany (Nov 7th, 2022) – Smart Reporting GmbH announced today that it will take part in the Imaging Artificial Intelligence in Practice...